Know Cancer

or
forgot password
  • cancer clinical trials in boston, MA

  • SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Colorectal Carcinoma
    SU011248 in Advanced Hepatocellular Carcinoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Hepatocellular Carcinoma, Liver Cancer
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    Boston Medical Center

    Trial Locations
    Boston Medical Center
    Brigham and Women's Hospital
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Floating Hospital for Children at Tufts - New England Medical Center

    Trial Locations
    Floating Hospital for Children at Tufts - New England Medical Center
    Massachusetts General Hospital
    Leukemia
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Tufts Medical Center Cancer Center
    Boston, Massachusetts 02111
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Multiple Myeloma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Floating Hospital for Children at Tufts Medical Center
    Boston, Massachusetts 02111
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Esophageal Cancer
    Short Course of Radiation for Gliomas in Elderly Patients
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    High Grade Gliomas
    Preoperative Treatment of Patients With High Risk Thymoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Thymoma
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Floating Hospital for Children at Tufts Medical Center
    Boston, Massachusetts 02111
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Esophageal Cancer, Stomach Cancer
    Treatment of Acute Lymphoblastic Leukemia in Children
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Drug/Agent Toxicity by Tissue/Organ, Leukemia
    Exercise Intervention in Women With Metastatic Breast Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Beth Isreal Deaconess Medical Center
    Breast Cancer
    A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
    Site Reference ID/Investigator# 40243
    Boston, Massachusetts 02115
    Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts 02114
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Breast Cancer, Metastatic Cancer
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    DFCI/Children's Hospital of Boston
    Boston, Massachusetts 02114
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Brigham & Womens Hospital

    Trial Locations
    Brigham & Womens Hospital
    Tufts Medical Center, Inc.
    Mycoses, Candidiasis, Invasive, Candidemia
    Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Waldenstrom's Macroglobulinemia